Results 241 to 244 of about 5,574 (244)

TRENDS IN PRICES AND CONSUMPTION OF BRANDED AND GENERIC OR BIOSIMILAR ANTINEOPLASTIC MEDICINES USED FOR SOLID TUMORS TREATMENT IN THE RUSSIAN PHARMACEUTICAL MARKET

2019
A. V. Nikitina, Filipp Vasilievich Gorkavenko, Saybel, Yegor Sergeevich, M. Avxentyeva, M. V. Sura   +4 more
openaire   +1 more source

Japanese regulation of biosimilar products: past experience and current challenges

British Journal of Clinical Pharmacology, 2016
exaly  

Survey on the Role of Comparative Efficacy Studies Required for Biosimilar Monoclonal Antibody Approval in Japan to Justify the Quality Attribute Differences Between Biosimilars and Their Reference Products Based on the Pharmaceuticals and Medical Devices Agency (PMDA) Assessments

Pharmaceutical Medicine
Kanoko Goto, Aya Hariu, Ryosuke Kuribayashi   +2 more
openaire   +1 more source

Pharmaceutical Patent Litigation and the Emerging Biosimilars: A Conversation with Kevin M. Nelson, JD.

American health & drug benefits
openaire   +1 more source